← Eichor
Condition: Ascvd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ascvd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NA · 3 location(s) · Indiana University · NCT05879913PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Phase 4 · 36 location(s) · Brigham and Women's Hospital · NCT05390892Penn Medicine Healthy Heart
NA · 1 location(s) · University of Pennsylvania · NCT06062394RESOLving INflammation Through Diet for Health (RESOLVIN)
NA · 5 location(s) · Mario Negri Institute for Pharmacological Research · NCT07331103CLAiR Pivotal Study
Phase N/A · 1 location(s) · Toku Eyes Ltd · NCT06808334Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Establish
Phase 3 · 95 location(s) · Novartis Pharmaceuticals · NCT06813911A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Dis
Phase 3 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT07551492Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
Phase 2 · 33 location(s) · Atom Therapeutics Co., Ltd · NCT07303777LDL Cholesterol TARGETs in OLDer Patients (Age≥75 Years) With ASCVD (TARGET OLD)
NA · 1 location(s) · China National Center for Cardiovascular Diseases · NCT05765370Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · 772 location(s) · Eli Lilly and Company · NCT07157774Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a
NA · 1 location(s) · Duke University · NCT06471036A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
Phase 1 · 2 location(s) · Monash University · NCT07428473Pelacarsen Roll-over Extension Program
Phase 3 · 97 location(s) · Novartis Pharmaceuticals · NCT06875973Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06691217Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NA · 9 location(s) · Nantes University Hospital · NCT06960902Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
Phase 1 · 16 location(s) · Verve Therapeutics, Inc. · NCT06451770The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
Phase N/A · 3 location(s) · Brigham and Women's Hospital · NCT07315997Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients W
NA · 1 location(s) · Colorado Prevention Center · NCT07334834Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Phase 3 · 13 location(s) · Hospital do Coracao · NCT06930885ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Phase 4 · 32 location(s) · Jung-min Ahn · NCT06676280Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dy
Phase 4 · 1 location(s) · Novartis Pharmaceuticals · NCT07034690The Long-term Effect of Remote Ischemic Conditioning on Main Organs in ASVCD Patients With Very High Risks
Phase N/A · 1 location(s) · General Hospital of Shenyang Military Region · NCT07270887Optimizing Non-statin Agents for ASCVD
Phase N/A · 1 location(s) · University of Texas at Austin · NCT07464574A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · 1365 location(s) · AstraZeneca · NCT07000357Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · 548 location(s) · CSL Behring · NCT05485961Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Phase N/A · 1 location(s) · Indiana University · NCT05611307TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD
Phase 1/Phase 2 · 1 location(s) · Hudson Biotech · NCT07487363Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Phase 2 · 59 location(s) · Kylonova (Xiamen) Biopharma co., LTD. · NCT07327840Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT06767774Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Phase N/A · 20 location(s) · Novartis Pharmaceuticals · NCT06858332
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.